HOUSTON — Houston police have located a 61-year-old man who disappeared Thursday evening and was previously believed to be in imminent danger, according to an update to the Houston Regional ...

The Texas Center for the Missing has issued a Houston Regional CLEAR Alert on behalf of the Houston Police Department for 61-year-old Alan Lee.

“Management is focused on implementing an action plan to recover cost increases and execute against our strong pipeline of new business” – Aleen Gulvanessian, chair Macfarlane Group, the ...

Linda was preceded in death by her parents, Aleen and Kenneth Heinz; her brother Mickey Heinz; her sister Marsha Paulson; and her in-laws Tom (Jan) Calvey, Karen (John) Nosch, Kelly (Eileen ...

Linda was preceded in death by her parents, Aleen and Kenneth Heinz; her brother Mickey Heinz; her sister Marsha Paulson; and her in-laws Tom (Jan) Calvey, Karen (John) Nosch, Kelly (Eileen ...

You generally expect separating couples to avoid each other once the split is made, but Katy Perry and Orlando Bloom are still spending time with each other and four-year-old daughter Daisy Dove.

MALVERN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced ...

Chair Aleen Gulvanessian commented: "It is disappointing that the momentum increase we experienced early in the second-quarter of 2025 has not been maintained and as a result will impact our full ...

Shares in Macfarlane Group tumbled today after the Glasgow-based packaging group issued a profits warning. In a trading update titled “reduction in full-year expectations”, Macfarlane Group ...

The company has added Jeffrey S. Heier, Peter K. Kaiser, and Arshad M. Khanani to its Scientific Advisory Board. Dr.

In 2021, Dr. Khanani founded the Clinical Trials at the Summit meeting to foster discussion on clinical trial design and data. Dr. Khanani has been recognized among the top 10 researchers globally ...

Ocugen updates its advisory board and leadership team to enhance expertise and pursue new gene therapies for blindness diseases.